Blume Capital Management, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Blume Capital Management, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$389
-13.0%
1,0000.0%0.00%
Q2 2023$447
-45.5%
1,0000.0%0.00%
Q1 2023$820
-47.4%
1,0000.0%0.00%
-100.0%
Q4 2022$1,560
-22.0%
1,0000.0%0.00%0.0%
Q3 2022$2,0000.0%1,0000.0%0.00%0.0%
Q2 2022$2,000
-50.0%
1,0000.0%0.00%0.0%
Q1 2022$4,000
-20.0%
1,0000.0%0.00%
-50.0%
Q4 2021$5,000
-28.6%
1,0000.0%0.00%
-33.3%
Q3 2021$7,000
-22.2%
1,0000.0%0.00%0.0%
Q2 2021$9,0000.0%1,0000.0%0.00%
-25.0%
Q1 2021$9,0000.0%1,0000.0%0.00%0.0%
Q4 2020$9,000
-25.0%
1,0000.0%0.00%
-33.3%
Q3 2020$12,000
-55.6%
1,0000.0%0.01%
-60.0%
Q2 2020$27,000
+285.7%
1,0000.0%0.02%
+275.0%
Q1 2020$7,000
+133.3%
1,0000.0%0.00%
+300.0%
Q4 2019$3,000
+50.0%
1,0000.0%0.00%0.0%
Q3 2019$2,000
-33.3%
1,0000.0%0.00%
-50.0%
Q2 2019$3,000
-25.0%
1,0000.0%0.00%0.0%
Q1 2019$4,0000.0%1,0000.0%0.00%0.0%
Q4 2018$4,000
-33.3%
1,0000.0%0.00%
-33.3%
Q3 2018$6,000
+50.0%
1,0000.0%0.00%
+50.0%
Q2 2018$4,0000.0%1,0000.0%0.00%0.0%
Q1 2018$4,0000.0%1,0000.0%0.00%0.0%
Q4 2017$4,000
-33.3%
1,0000.0%0.00%
-33.3%
Q3 2017$6,000
-25.0%
1,0000.0%0.00%
-40.0%
Q2 2017$8,000
+14.3%
1,0000.0%0.01%
+25.0%
Q1 2017$7,0000.0%1,0000.0%0.00%0.0%
Q4 2016$7,000
-22.2%
1,0000.0%0.00%
-33.3%
Q3 2016$9,0001,0000.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders